Koshkaryev A - Search Results

1

Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Koshkaryev A, Sawant R, Deshpande M, Torchilin V. Koshkaryev A, et al. Adv Drug Deliv Rev. 2013 Jan;65(1):24-35. doi: 10.1016/j.addr.2012.08.009. Epub 2012 Sep 3. Adv Drug Deliv Rev. 2013. PMID: 22964425 Free PMC article. Review.

2

Kinetic and thermodynamic approaches to the drug targeting phenomena.

Meerovich I, Koshkaryev A, Torchilin VP. Meerovich I, et al. Among authors: koshkaryev a. Curr Drug Discov Technol. 2011 Dec 1;8(4):287-300. doi: 10.2174/157016311798109335. Curr Drug Discov Technol. 2011. PMID: 21726187 Review.

3

Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B.

Koshkaryev A, Thekkedath R, Pagano C, Meerovich I, Torchilin VP. Koshkaryev A, et al. J Drug Target. 2011 Sep;19(8):606-14. doi: 10.3109/1061186X.2010.550921. Epub 2011 Jan 29. J Drug Target. 2011. PMID: 21275828 Free PMC article.

4

Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting.

Biswas S, Dodwadkar NS, Sawant RR, Koshkaryev A, Torchilin VP. Biswas S, et al. Among authors: koshkaryev a. J Drug Target. 2011 Aug;19(7):552-61. doi: 10.3109/1061186X.2010.536983. Epub 2011 Feb 25. J Drug Target. 2011. PMID: 21348804 Free PMC article.

5

Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes.

Koshkaryev A, Piroyan A, Torchilin VP. Koshkaryev A, et al. Cancer Biol Ther. 2012 Jan 1;13(1):50-60. doi: 10.4161/cbt.13.1.18871. Cancer Biol Ther. 2012. PMID: 22336588 Free PMC article.

6

Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.

Koshkaryev A, Piroyan A, Torchilin VP. Koshkaryev A, et al. Cancer Lett. 2013 Jul 1;334(2):293-301. doi: 10.1016/j.canlet.2012.06.008. Epub 2012 Jun 25. Cancer Lett. 2013. PMID: 22743614 Free PMC article.

7

The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.

Sawant RR, Jhaveri AM, Koshkaryev A, Qureshi F, Torchilin VP. Sawant RR, et al. Among authors: koshkaryev a. J Drug Target. 2013 Aug;21(7):630-8. doi: 10.3109/1061186X.2013.789032. Epub 2013 Apr 17. J Drug Target. 2013. PMID: 23594094

8

Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.

Apte A, Koren E, Koshkaryev A, Torchilin VP. Apte A, et al. Among authors: koshkaryev a. Cancer Biol Ther. 2014 Jan;15(1):69-80. doi: 10.4161/cbt.26609. Epub 2013 Oct 21. Cancer Biol Ther. 2014. PMID: 24145298 Free PMC article.

9

Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma.

Sawant RR, Jhaveri AM, Koshkaryev A, Zhu L, Qureshi F, Torchilin VP. Sawant RR, et al. Among authors: koshkaryev a. Mol Pharm. 2014 Feb 3;11(2):375-81. doi: 10.1021/mp300633f. Epub 2013 Dec 19. Mol Pharm. 2014. PMID: 24325630

10

Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro.

Thekkedath R, Koshkaryev A, Torchilin VP. Thekkedath R, et al. Among authors: koshkaryev a. Nanomedicine (Lond). 2013 Jul;8(7):1055-65. doi: 10.2217/nnm.12.138. Epub 2012 Dec 2. Nanomedicine (Lond). 2013. PMID: 23199221 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters